CRA_9076
Star0
Identification
- Generic Name
- CRA_9076
- DrugBank Accession Number
- DB04215
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 344.206
Monoisotopic: 343.032024732 - Chemical Formula
- C16H14BrN3O
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UTrypsin-1 Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as 2-phenylindoles. These are indoles substituted at the 2-position with a phenyl group.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Indoles and derivatives
- Sub Class
- Indoles
- Direct Parent
- 2-phenylindoles
- Alternative Parents
- Phenylpyrroles / Para cresols / O-bromophenols / Toluenes / Bromobenzenes / Aryl bromides / Heteroaromatic compounds / Carboximidamides / Carboxamidines / Azacyclic compounds show 4 more
- Substituents
- 2-bromophenol / 2-halophenol / 2-phenylindole / 2-phenylpyrrole / Amidine / Aromatic heteropolycyclic compound / Aryl bromide / Aryl halide / Azacycle / Benzenoid show 19 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- BVTBOJXEAPSOEB-UHFFFAOYSA-N
- InChI
- InChI=1S/C16H14BrN3O/c1-8-4-11(15(21)12(17)5-8)14-7-10-6-9(16(18)19)2-3-13(10)20-14/h2-7,20-21H,1H3,(H3,18,19)
- IUPAC Name
- 2-{5-[amino(iminiumyl)methyl]-1H-indol-2-yl}-6-bromo-4-methylbenzen-1-olate
- SMILES
- CC1=CC(Br)=C([O-])C(=C1)C1=CC2=CC(=CC=C2N1)C(N)=[NH2+]
References
- General References
- Not Available
- External Links
- PubChem Compound
- 447508
- PubChem Substance
- 46507467
- ChemSpider
- 394577
- BindingDB
- 50101873
- ChEMBL
- CHEMBL48608
- ZINC
- ZINC000033359893
- PDBe Ligand
- 907
- PDB Entries
- 1o3h / 1o3i
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.00141 mg/mL ALOGPS logP 1.21 ALOGPS logP 3.21 Chemaxon logS -5.4 ALOGPS pKa (Strongest Acidic) 8.19 Chemaxon pKa (Strongest Basic) 11.21 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 90.46 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 109.83 m3·mol-1 Chemaxon Polarizability 33.56 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9928 Blood Brain Barrier + 0.9545 Caco-2 permeable - 0.5997 P-glycoprotein substrate Non-substrate 0.6045 P-glycoprotein inhibitor I Non-inhibitor 0.9276 P-glycoprotein inhibitor II Non-inhibitor 0.6565 Renal organic cation transporter Non-inhibitor 0.6466 CYP450 2C9 substrate Non-substrate 0.7113 CYP450 2D6 substrate Non-substrate 0.786 CYP450 3A4 substrate Non-substrate 0.6112 CYP450 1A2 substrate Inhibitor 0.833 CYP450 2C9 inhibitor Inhibitor 0.5978 CYP450 2D6 inhibitor Non-inhibitor 0.5225 CYP450 2C19 inhibitor Inhibitor 0.6782 CYP450 3A4 inhibitor Non-inhibitor 0.5231 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.7965 Ames test Non AMES toxic 0.5591 Carcinogenicity Non-carcinogens 0.8784 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.6763 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9598 hERG inhibition (predictor II) Non-inhibitor 0.628
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-0006-2019000000-745aeec0a92414f72a19 Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-002f-0009000000-256eb77bf5bd1377485d Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-004l-0009000000-6464841528d7e6d8be19 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0006-0009000000-6a1325b4475c8fc1deec Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-00fs-0096000000-1072d26f2d2ab7752487 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-08fu-1319000000-a1e4e89ca420fff34b3c Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-02ai-3695000000-766a71e1adf220c02dca Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 160.8395 predictedDeepCCS 1.0 (2019) [M+H]+ 163.19746 predictedDeepCCS 1.0 (2019) [M+Na]+ 169.3007 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsTrypsin-1
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Serine-type endopeptidase activity
- Specific Function
- Has activity against the synthetic substrates Boc-Phe-Ser-Arg-Mec, Boc-Leu-Thr-Arg-Mec, Boc-Gln-Ala-Arg-Mec and Boc-Val-Pro-Arg-Mec. The single-chain form is more active than the two-chain form aga...
- Gene Name
- PRSS1
- Uniprot ID
- P07477
- Uniprot Name
- Trypsin-1
- Molecular Weight
- 26557.88 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52